Learning Objectives:

Learning objectives:

1. Explain the complex symptoms of Amyloidosis
2. Facilitate multidisciplinary care for patients with amyloidosis disease
3. Screen amyloidosis patients for clinical trials
4. Discuss current amyloidosis research

Direct Accreditation:
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Faculty, Planning Committee, and CME Administrator disclosure statement:

John Berk, MD, Presenter, is a study site investigator and consultant for: Alnylam Pharmaceuticals, Ionis Pharmaceutical, Eidos Therapeutics, Intellia Therapeutics, Corino Therapeutics, and Akcea on clinical trials conduct and design.

Sakina Flint, Program Manager, has no relevant financial relationships to disclose.


Faculty disclosure of off-label use: 
Faculty member plans on discussing diflunisal -- an NSAID demonstrated to alter the course of ATTR amyloidosis disease.


Faculty disclosure policy:
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.


Disclaimer: 
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

 

Copyright:
© Trustees of Boston University, 2020/2021

Session date: 
12/17/2021 - 10:30am to 12:00pm EST
Location: 
Boston University School of Medicine
United States
  • 1.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 Participation
Please login or register to take this course.